The i-SIGHT2 pivotal trial is evaluating a noninvasive office-based bioelectric therapy for intermediate to advanced dry age-related macular degeneration. ...
Disruptive innovation provides NHS Trusts faster access to continuous IV monitoring to reduce avoidable extravasation harm...
Six health systems and organizations awarded funding to improve patient access to cancer care through optimizing molecular testing pathways, biomarker-driven treatment selection, and precision oncology implementation in metastatic colorectal cancer...
The advancement of ADC 2.0 candidates AK146D1 and AK138D1 into Phase II trials marks a critical milestone for Akeso's "IO2.0 + ADC2.0" strategy...
The first-in-human study showed that wearable auricular neurostimulation enhanced platelet function without systemic effects or adverse events....
Findings from the multi-center Articulate Pro study show Paige Prostate improves diagnostic consistency, accelerates turnaround times, and reduces laboratory workloads...
The disease is projected to become the fifth leading cause of death by 2040 if diagnosis and treatment rates do not improve...
The antibody has been selected by Abbott, Beckman-Coulter Diagnostics, Roche, Siemens Healthineers, Alamar Biosciences, Bio-Techne and Quanterix for the development of research and clinical pTau217 assays...
A blood test for Alzheimer's disease biomarkers helped improve diagnostic accuracy among specialists and primary care physicians in a real-world study...
The ENHANCE early feasibility study is evaluating the investigational CARLEN System for symptomatic functional mitral regurgitation....
